363 related articles for article (PubMed ID: 15166851)
1. Guidelines for community-acquired pneumonia in the ICU.
Wilkinson M; Woodhead MA
Curr Opin Crit Care; 2004 Feb; 10(1):59-64. PubMed ID: 15166851
[TBL] [Abstract][Full Text] [Related]
2. [Guidelines for treatment of pneumonia in intensive care units].
Emmi V
Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
[TBL] [Abstract][Full Text] [Related]
3. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study.
Carugati M; Aliberti S; Sotgiu G; Blasi F; Gori A; Menendez R; Encheva M; Gallego M; Leuschner P; Ruiz-Buitrago S; Battaglia S; Fantini R; Pascual-Guardia S; Marin-Corral J; Restrepo MI;
Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1513-1525. PubMed ID: 32242314
[TBL] [Abstract][Full Text] [Related]
4. [Community acquired pneumonia - treatment options according to the international recommendations].
Lewandowska K; Kuś J
Wiad Lek; 2016; 69(2 Pt 1):139-44. PubMed ID: 27421128
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of fulminant community-acquired Pseudomonas aeruginosa necrotizing pneumonia in a previously healthy young man.
Kunimasa K; Ishida T; Kimura S; Tanaka M; Kouyama Y; Yamashita S; Morita M; Tachibana H; Tokioka F; Ito A; Sumi C; Tateda K
Intern Med; 2012; 51(17):2473-8. PubMed ID: 22975571
[TBL] [Abstract][Full Text] [Related]
6. Severe community-acquired pneumonia, shock and multiorgan dysfunction syndrome caused by Chlamydia pneumoniae.
Marik PE; Iglesias J
J Intern Med; 1997 May; 241(5):441-4. PubMed ID: 9183314
[TBL] [Abstract][Full Text] [Related]
7. The role of new therapies for severe community-acquired pneumonia.
Restrepo MI; Anzueto A
Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
[TBL] [Abstract][Full Text] [Related]
8. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood].
Ouchi K
Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086
[TBL] [Abstract][Full Text] [Related]
9. Role of Atypical Pathogens in the Etiology of Community-Acquired Pneumonia.
Arnold FW; Summersgill JT; Ramirez JA
Semin Respir Crit Care Med; 2016 Dec; 37(6):819-828. PubMed ID: 27960206
[TBL] [Abstract][Full Text] [Related]
10. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS
Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051
[TBL] [Abstract][Full Text] [Related]
11. [Chlamydia pneumoniae and other Chlamydia species in community-acquired pneumonia].
Ruiz Carmona M; Soler Polcar N; Torres Martí A
Rev Clin Esp; 1998 Sep; 198 Suppl 1():30-4. PubMed ID: 9835771
[No Abstract] [Full Text] [Related]
12. Bacterial Pathogens Associated with Community acquired Pneumonia : Authors Reply.
Saikia L
Indian Pediatr; 2016 Aug; 53(8):749-50. PubMed ID: 27567659
[No Abstract] [Full Text] [Related]
13. Antimicrobial therapy in community-acquired pneumonia among emergency patients in a university hospital in Japan.
Kawai S; Ochi M; Nakagawa T; Goto H
J Infect Chemother; 2004 Dec; 10(6):352-8. PubMed ID: 15614461
[TBL] [Abstract][Full Text] [Related]
14. Severe community-acquired pneumonia.
Cassiere HA; Fein AM
Curr Opin Pulm Med; 1996 May; 2(3):186-91. PubMed ID: 9363138
[TBL] [Abstract][Full Text] [Related]
15. The hospitalist perspective on treatment of community-acquired bacterial pneumonia.
Amin AN; Cerceo EA; Deitelzweig SB; Pile JC; Rosenberg DJ; Sherman BM
Postgrad Med; 2014 Mar; 126(2):18-29. PubMed ID: 24685965
[TBL] [Abstract][Full Text] [Related]
16. [Atypical pneumonias (mycoplasmic, chlamydial and legionellous)].
Sokolova VI
Antibiot Khimioter; 2007; 52(11-12):35-40. PubMed ID: 19275056
[No Abstract] [Full Text] [Related]
17. Japanese guidelines for the management of community-acquired pneumonia.
Yanagihara K; Kohno S; Matsusima T
Int J Antimicrob Agents; 2001; 18 Suppl 1():S45-8. PubMed ID: 11574195
[TBL] [Abstract][Full Text] [Related]
18. The science of selecting antimicrobials for community-acquired pneumonia (CAP).
File TM
J Manag Care Pharm; 2009 Mar; 15(2 Suppl):S5-11. PubMed ID: 19236135
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.
Kontou P; Kuti JL; Nicolau DP
Am J Emerg Med; 2009 Oct; 27(8):968-74. PubMed ID: 19857416
[TBL] [Abstract][Full Text] [Related]
20. Severity assessment in community-acquired pneumonia.
Ewig S; Schäfer H; Torres A
Eur Respir J; 2000 Dec; 16(6):1193-201. PubMed ID: 11292126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
